CSIRO, Australia’s national science agency, will develop new medicinal cannabis products to help people with a variety of conditions including multiple sclerosis and chronic pain. Under a new licence, CSIRO will support the burgeoning local industry and partner with local manufacturers to drive the development of new cannabis therapeutics, in […]